[New medicinal treatment possibilities of angiopathy in diabetics with 3-(methyloxyethylamino)-2-oxyprophyltheophylline nicotinate (complamin)].
D002318:Cardiovascular Diseases / Q000209:etiology*; D048909:Diabetes Complications; D003920:Diabetes Mellitus; D009525:Niacin / Q000031:analogs & derivatives; D009539:Nicotinic Acids; D013806:Theophylline / Q000031:analogs & derivatives; D014652:Vascular Diseases; D014971:Xanthinol Niacinate
D009539:Nicotinic Acids; D009525:Niacin; D014971:Xanthinol Niacinate; D013806:Theophylline
CARDIOVASCULAR DISEASES/etiology and pathogenesis; DIABETES MELLITUS/complications; NICOTINIC ACID/related compounds; THEOPHYLLINE/related compounds
Neue medikamentöse Behandlungsmöglichkeiten der Angiopathien bei Diabetikern mit 3-(Methyl-oxyäthylamino)-2-(oxypropyltheophyllin) -nikotinat (Complamin).